Syndrome  >>  tenofovir disoproxil fumarate  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tenofovir disoproxil fumarate / Generic mfg.
NCT00034086: Study of Anti-HIV Therapy Intensification

Completed
N/A
22
US
Lopinavir/Ritonavir, Lamivudine/Zidovudine, Tenofovir disoproxil fumarate, Pneumococcal Vaccine, Polyvalent (23-valent), Lamivudine, Stavudine, Zidovudine, Didanosine, Lyme Disease Vaccine Recombinant OspA, Haemophilus B Conjugate Vaccine
National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
 
06/06
NCT00109603: Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy

Completed
N/A
17
US
Tenofovir disoproxil fumarate
National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections, Dyslipidemia, Hyperlipidemia, Hypercholesterolemia, Hypertriglyceridemia
07/07
11/07
NCT00312169: Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA)

Completed
N/A
20
US
Orlando Immunology Center, GlaxoSmithKline
HIV Infections
05/08
05/08
COVER, NCT00705419 / 2006-003463-31: Registry to Assess Long-term Outcome in HIV Subjects Who Participated in Phase 2 and 3 Clinical Trials Involving Vicriviroc (Study P04999)

Completed
N/A
180
US
Vicriviroc maleate, SCH 417690, Placebo, Emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg, Truvada
Merck Sharp & Dohme LLC
HIV Infections
09/10
09/10
NCT00666055: Sex, Aging and Antiretroviral Pharmacokinetics

Completed
N/A
11
US
ARV regimen chosen by treating physician, Zidovudine: ZDV, Retrovir, Retrovis, AZT (Azidothymidine), Lamivudine: 3TC, Zeffix, Epivir, Epivir-HBV, Emtricitabine: FTC, Emtriva, Abacivir: Ziagen, Tenofovir: TDF, Viread, Efavirenz: Sustiva, Stocrin, Lopinavir/Ritonavir: Kaletra, Aluvia, Atazanavir: Reyataz, Ritonavir: Norvir, Maraviroc: Selzentry, Raltegravir: MK-0518, Isentress, Etravirine: TMC-125, Intelence
Kristine Patterson, MD, National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
05/12
05/12
NCT00977756: IMPAACT P1058A: Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults

Completed
N/A
168
US
Raltegravir (RAL), Isentress, Atazanavir (ATV), Reyataz, Ritonavir (RTV), Norvir, Tenofovir (TDF), Viread, Etravirine (ETV), Intelence, Darunavir (DRV), Prezista, Maraviroc (MVC), Selzentry, Lopinavir/ritonavir (LPV/r), Kaletra
International Maternal Pediatric Adolescent AIDS Clinical Trials Group, National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
03/14
03/14

Download Options